Henry A. Mckinnell - 20 May 2022 Form 4 Insider Report for ChemoCentryx, Inc.

Reporting relationship: Director
Issuer ticker: N/A
Reported as of: 20 May 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 24 May 2022, 19:34:12 UTC
Prior SEC filing: 24 May 2021
Source filing: View source filing
Reporting owner signature: /s/ Susan M. Kanaya, as Attorney-in-Fact

Key filing fact

Henry A. Mckinnell filed Form 4 for ChemoCentryx, Inc. on 24 May 2022.

Key facts

This page summarizes Henry A. Mckinnell's Form 4 filing for ChemoCentryx, Inc..
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 24 May 2022, 19:34.

Change

Previous filing in this sequence was filed on 24 May 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CCXI transaction

Common Stock

Options Exercise

Transaction value: $0
Shares: +7,726
Change %: +12%
Price: $0.000000
Shares after: 72,749
Date: 20 May 2022
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CCXI transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares: -7,726
Change %: -100%
Price
Shares after: 0
Date: 20 May 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 7,726
Exercise price
Footnotes: F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Shares were acquired upon vesting of restricted stock units awarded on May 20, 2021.

Footnote F2

Each restricted stock unit represents a contingent right to receive one share of CCXI common stock.

Footnote F3

100% of the restricted stock units vested on May 20, 2022. Vested shares will be delivered to the Reporting Person within thirty (30) days following vest date.